Paul Clark

Mr. Paul N. Clark is an Independent Director at Agenus, Inc., a Lead Independent Non-Executive Director at Keysight Technologies, Inc., an Independent Director at Agilent Technologies, Inc. and a President & Chief Executive Officer at Lilly ICOS LLC. He is on the Board of Directors at Agenus, Inc., Keysight Technologies, Inc., Agilent Technologies, Inc. and Grifols Therapeutics, Inc. Mr. Clark was previously employed as an Independent Director by Amylin Pharmaceuticals, Inc., an Operating Partner by Genstar Capital LLC, a Chairman by ICOS Corp., a Director & Executive Vice President by Abbott Laboratories, a Vice President-Sales & Marketing by Marion Laboratories, and an Operating Partner & Advisor by Genstar Capital Management LLC. He also served on the board at BIOLASE, Inc., Talecris Biotherapeutics Holdings Corp., Catalent Pharma Solutions, Inc., Catalent, Inc., Cerevast Neurorehab, Inc. and Harlan Laboratories, Inc. He received his undergraduate degree from The University of Alabama and an MBA from Tuck School of Business at Dartmouth.